- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Outreach
- Careers
- About
- For Pain Patients and Professionals
Papers: 11 Mar 2023 - 17 Mar 2023
RESEARCH TYPE:
Clinical, Pediatric
Human Studies, Pharmacology/Drug Development
PAIN TYPE:
Migraine/Headache
2023 Feb 23
J Clin Med
12
5
The use of OnabotulinumtoxinA (OBT-A) for the treatment of chronic migraine (CM) in adults represents a therapy with the greatest efficacy and safety data. However, we have little evidence on the use of OBT-A in children or adolescents. The present study aims to describe the experience with OBT-A in the treatment of CM in adolescents in an Italian third-level headache center.